Inventor · disambiguated record
Konstanze Hurth
Also filed as: HURTH KONSTANZE
27 granted patents·17 pending applications·215 citations·filing 2002–2023
96Inventor score
Top patents by PatentIndex Score
44 records- 0195US8637508B2Heterocyclic derivatives and their use in the treatment of neurological disordersBADIGER SANGAMESH·Filed 2012·Granted Jan 28, 2014·75 cites·25 claims
- 0292US7579362B2Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonistsNOVARTIS AG·Filed 2007·Granted Aug 25, 2009·17 cites·13 claims
- 0391US7713976B2[(1H-indol-5-yl)-heteroaryloxy]-1-aza-bicylco[3.3.1]nonanes as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenerative disordersNOVARTIS AG·Filed 2006·Granted May 11, 2010·19 cites·6 claims
- 0491US7713977B2(1-aza-bicyclo[3.3.1]non-4-yl)-[5-(1H-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disordersNOVARTIS AG·Filed 2006·Granted May 11, 2010·20 cites·16 claims
- 0589US8609662B23-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha. 7-nachr ligands for the treatment of CNS diseasesFEUERBACH DOMINIK·Filed 2009·Granted Dec 17, 2013·13 cites·12 claims
- 0688US9475811B21-aza-bicyclo[3.3.1]nonanesNOVARTIS AG·Filed 2014·Granted Oct 25, 2016·11 cites·6 claims
- 0787US8933090B21-aza-bicyclo[3.3.1]nonanesFEUERBACH DOMINIK·Filed 2010·Granted Jan 13, 2015·11 cites·6 claims
- 0885US9763952B2Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivativesCARAVATTI GIORGIO·Filed 2015·Granted Sep 19, 2017·9 cites·10 claims
- 0985US8865712B2Heterocyclic derivatives and their use in the treatment of neurological disordersBADIGER SANGAMESH·Filed 2013·Granted Oct 21, 2014·7 cites·16 claims
- 1083US10035794B2Heterocyclic derivatives and their use in the treatment of neurological disordersNOVARTIS AG·Filed 2016·Granted Jul 31, 2018·3 cites·8 claims
- 1182US9550758B2Heterocyclic derivatives and their use in the treatment of neurological disordersBADIGER SANGAMESH·Filed 2014·Granted Jan 24, 2017·4 cites·6 claims
- 1282US8048885B2Organic compoundsNOVARTIS AG·Filed 2010·Granted Nov 1, 2011·5 cites·8 claims
- 1377US8637517B2Organic compoundsFEUERBACH DOMINIK·Filed 2011·Granted Jan 28, 2014·3 cites·13 claims
- 1476US10301296B2Heterocyclic derivatives and their use in the treatment of neurological disordersNOVARTIS AG·Filed 2018·Granted May 28, 2019·1 cites·12 claims
- 1575US8236803B2Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonistsFEUERBACH DOMINIK·Filed 2008·Granted Aug 7, 2012·1 cites·12 claims
- 1674US9012451B2Aza-bicycloalkyl ethers and their use as ALPHA7-nachr agonistsFEUERBACH DOMINIK·Filed 2012·Granted Apr 21, 2015·1 cites·19 claims
- 1774US6861430B2β-carboline derivatives and its pharmaceutical use against depression and anxietyNOVARTIS AG·Filed 2002·Granted Mar 1, 2005·7 cites·6 claims
- 1873US9567343B2Aza-bicyloalkyl ethers and their use as alpha7-nachr agonistsNOVARTIS AG·Filed 2015·Granted Feb 14, 2017·1 cites·6 claims
- 1972US9284284B2Oxazine derivatives and their use in the treatment of diseaseHURTH KONSTANZE·Filed 2012·Granted Mar 15, 2016·4 cites·19 claims
- 2071US10683287B2Heterocyclic derivatives and their use in the treatment of neurological disordersNOVARTIS AG·Filed 2019·Granted Jun 16, 2020·0 cites·2 claims
- 2168US8759346B2Organic compoundsFREDERIKSEN MATHIAS·Filed 2010·Granted Jun 24, 2014·2 cites·13 claims
- 2266US2019083474A1Aza-bicycloalkyl ethers and their use as alpha7-nachr agonistsNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2364US9849117B2Aza-bicycloalkyl ethers and their use as alpha7-nachr agonistsNOVARTIS AG·Filed 2017·Granted Dec 26, 2017·0 cites·5 claims
- 2464US9840498B2Substituted quinazolin-4-one derivativesNOVARTIS AG·Filed 2014·Granted Dec 12, 2017·1 cites·15 claims
- 2563US2018078536A1Aza-bicycloalkyl ethers and their use as alpha7-nachr agonistsNOVARTIS AG·Filed 2017·Application pending·0 cites
- 2662US2025223277A1Complement factor b inhibitors and uses thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 2761US9206181B21-aza-bicyclo[3.3.1] non-4-yl)-[5-(1H-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenerative disordersNOVARTIS AG·Filed 2014·Granted Dec 8, 2015·0 cites·12 claims
- 2861US2025115572A1Spirocyclic piperidinyl derivatives as complement factor b inhibitors and uses thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 2960US2015018338A1Oxazine derivatives and their use in the treatment of neurological disordersBADIGER SANGAMESH·Filed 2014·Application pending·0 cites
- 3059US9657010B2Substituted quinuclidines as alpha 7-nicotinic acetylcholine receptor activity modulatorsNOVARTIS AG·Filed 2013·Granted May 23, 2017·0 cites·12 claims
- 3159US2014113908A1[(1h-indol-5-yl) - heteroaryloxy] - (1-aza-bicyclo [3.3.1] nonanes as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenrative disordersNOVARTIS AG·Filed 2013·Application pending·0 cites
- 3256US2006167002A1Aza-bicycloalkyl ethers and their use as alpha7-nachr agonistsFEUERBACH DOMINIK·Filed 2003·Application pending·0 cites
- 3353US2008194573A13-(Heteroaryl-Oxy)-2-Alkyl-1-Aza-Bicycloalkyl Derivatives As Alpha. 7-Nachrligands For TheTreatment Of Cns DiseasesNOVARTIS AG·Filed 2005·Application pending·0 cites
- 3453US2007249657A11-Aza-Bicyclo3.3.1NonanesFEUERBACH DOMINIK·Filed 2005·Application pending·0 cites
- 3549US9539260B2Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivativesNOVARTIS AG·Filed 2012·Granted Jan 10, 2017·0 cites·19 claims
- 3648US2011195950A1Organic CompoundsNOVARTIS AG·Filed 2008·Application pending·0 cites
- 3748US2011294799A1Organic CompoundsHINTERMANN SAMUEL·Filed 2008·Application pending·0 cites
- 3846US7754719B2Substituted piperidine derivatives as somatostatin SST1 receptor antagonistsNOVARTIS AG·Filed 2006·Granted Jul 13, 2010·0 cites·5 claims
- 3946US2012172359A1Oxazine Derivatives and their Use in the Treatment of Neurological DisordersBADIGER SANGAMESH·Filed 2012·Application pending·0 cites
- 4044US2012302558A1Oxazine derivatives and their use in the treatment of neurological disordersBADIGER SANGAMESH·Filed 2011·Application pending·0 cites
- 4144US2008306081A1Combinations of Nicotinic Acetylcholine Alpha 7 Receptor AntagonistsNOVARTIS AG·Filed 2005·Application pending·0 cites
- 4236US2015148377A1Quinoline DerivativesHOGENAUER KLEMENS·Filed 2012·Application pending·0 cites
- 4336US2010125063A1Combinations of nicotinic acetylcholine alpha 7 receptor agonistsNOVARTIS AG·Filed 2010·Application pending·0 cites
- 4433US2013281449A1Oxazine Derivatives and their Use in the Treatment of Neurological DisordersHURTH KONSTANZE·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Konstanze Hurth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →